Clostridium botulinum type A progenitor toxin binds to Intestine-407 cells via N-acetyllactosamine moiety

Biochemical and Biophysical Research Communications

Volumn 331, Issue 2, 2005, Pages 571-576

  Kojima, Shoudou ^a   Eguchi, Hironobu ^a   Ookawara, Tomomi ^a   Fujiwara, Noriko ^a   Yasuda, Jun ^a   Nakagawa, Kazuhiko ^a   Yamamura, Takehira ^a   Suzuki, Keiichiro ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Clostridium botulinum type A progenitor toxin; Fucose; Intestine 407 cells; N Acetyllactosamine; N Acetylneuraminic acid; N linked oligosaccharides

Indexed keywords

BOTULINUM TOXIN A; CARBOHYDRATE; GALACTOSE; GLUCOSIDASE; GLYCOSIDASE; LACTOSE; N ACETYLGLUCOSAMINE; N ACETYLLACTOSAMINE; N ACETYLNEURAMINIC ACID; OLIGOSACCHARIDE; SIALIDASE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING ASSAY; CELL SURFACE; FUCOSYLATION; HUMAN; HUMAN CELL; INTESTINE CELL; NONHUMAN; PRIORITY JOURNAL; SIALYLATION;

CLOSTRIDIUM BOTULINUM;

EID: 18044376812     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.04.007     Document Type: Article

References (33)

1. K. Inoue, Y. Fujinaga, T. Wanatabe, T. Ohyama, K. Takeshi, K. Moriishi, H. Nakajima, K. Inoue, and K. Oguma Molecular composition of Clostridium botulinum type A progenitor toxins Infect. Immun. 64 1996 1589 1594
2. K. Oguma, Y. Fujinaga, and K. Inoue Structure and function of Clostridium botulinum toxins Microbiol. Immunol. 39 1995 161 168
3. Y. Fujinaga, K. Inoue, S. Shimazaki, K. Tomochika, K. Tsuzuki, N. Fujii, T. Watanabe, T. Ohyama, K. Takeshi, and K. Oguma Molecular construction of Clostridium botulinum type C progenitor toxin and its gene organization Biochem. Biophys. Res. Commun. 205 1994 1291 1298
4. J.K. Tsui, A. Eisen, E. Mak, J. Carruthers, A. Scott, and D.B. Calne A pilot study on the use of botulinum toxin in spasmodic torticollis Can. J. Neurol. Sci. 12 1985 314 316
5. B.R. Frueh, D.P. Felt, T.H. Wojno, and D.C. Musch Treatment of blepharospasm with botulinum toxin. A preliminary report Arch. Ophthalmol. 102 1984 1464 1468
6. R. Jahn, and H. Niemann Molecular mechanisms of clostridial neurotoxins Ann. N.Y. Acad. Sci. 733 1994 245 255
7. C. Montecucco, and G. Schiavo Mechanism of action of tetanus and botulinum neurotoxins Mol. Microbiol. 13 1994 1 8
8. K.A. Karlsson Animal glycosphingolipids as membrane attachment sites for bacteria Annu. Rev. Biochem. 58 1989 309 350
9. K. Sandvig Membrane traffic exploited by protein toxins Annu. Rev. Cell. Dev. Biol. 18 2002 1 24
10. M.L. Philips, E. Nudelman, F.C.A. Gaeta, M. Perez, A.K. Singhal, S. Hakomori, and J.C. Paulson ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex Science 250 1990 1130 1132
11. G. Walz, A. Aruffo, W. Kolanus, M. Bevilacqua, and B. Seed Recognition by ELAM-1 of the sialyl-Lex determinant on myeloid and tumor cells Science 250 1990 1132 1135
12. J. Lesley, R. Hyman, and P.W. Kincade CD44 and its interaction with extracellular matrix Adv. Immunol. 54 1993 271 335
13. A. Frey, K.T. Giannasca, R. Weltzin, P.J. Giannasca, H. Reggio, W.I. Lencer, and M.R. Neutra Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting J. Exp. Med. 184 1996 1045 1059
14. Y. Abe, C.W. Smith, J.P. Katkin, L.M. Thurmon, X. Xu, L.H. Mendoza, and C.M. Ballantyne Endothelial alpha 2,6-linked sialic acid inhibits VCAM-1-dependent adhesion under flow conditions J. Immunol. 163 1999 2867 2876
15. M. Jacewicz, H. Clausen, E. Nudelman, A. Donohue-Rolfe, and G.T. Kesch Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide J. Exp. Med. 163 1986 1391 1404
16. H. Nakajima, N. Kiyokawa, Y.U. Katagiri, T. Taguchi, T. Suzuki, T. Seikino, K. Mimori, T. Ebata, M. Saito, H. Nakao, T. Takeda, and J. Fujimoto Kinetic analysis of binding between Shiga toxin and receptor glycolipid Gb3Cer by surface plasmon resonance J. Biol. Chem. 276 2001 42915 42922
17. S.A. Kaye, C.B. Louise, B. Boyd, C.A. Lingwood, and T.G. Obrig Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells invitro Infect. Immun. 61 1993 3886 3891
18. C.B. Louise, S.A. Kaye, B. Boyd, C.A. Lingwood, and T.G. Obrig Shiga toxin-associated hemolytic uremic syndrome: effect of sodium butyrate on sensitivity of human umbilical vein endothelial cells to Shiga toxin Infect. Immunol. 63 1995 2766 2769
19. P.E. Stein, G.D. Boodhoo, L.D. Heerze, S.A. Cockle, M.H. Klein, and R.J. Read Structure of a pertussis toxin-sugar complex as a model for receptor binding Nat. Struct. Biol. 1 1994 591 596
20. Y. Fujinaga, K. Inoue, T. Nomura, J. Sasaki, J.C. Marvaud, M.R. Popoff, S. Kozaki, and K. Oguma Identification and characterization of functional subunits of Clostridium botulinum type A progenitor toxin involved in binding to intestinal microvilli and erythrocytes FEBS. Lett. 467 2000 179 183
21. Y. Fujinaga, K. Inoue, S. Watarai, Y. Sakaguchi, H. Arimitsu, J. Lee, Y. Jin, T. Matsumura, Y. Kabumoto, T. Watanabe, T. Ohyama, A. Nishikawa, and K. Oguma Molecular characterization of binding subcomponents of Clostridium botulinum type C progenitor toxin for intestinal epithelial cells and erythrocytes Microbiology 150 2004 1529 1538
22. K. Takamizawa, M. Iwamori, S. Kozaki, G. Sakaguchi, R. Tanaka, H. Takayama, and Y. Nagai TLC immunostaining characterization of Clostridium botulinum type A neurotoxin binding to gangliosides and free fatty acids FEBS. Lett. 201 1986 229 232
23. Y. Kamata, M. Yoshimoto, and S. Kozaki Interaction between botulinum neurotoxin type A and ganglioside:ganglioside inactivates the neurotoxin and quenches its tryptophan fluorescence Toxicon 35 1997 1337 1340
24. B.C. Yowler, R.D. Kensinger, and C.L. Schengrund Botulinum neurotoxin A activity is dependent upon the presence of specific gangliosides in neuroblastoma cells expressing synaptotagmin I J. Biol. Chem. 277 2002 32815 32819
25. K. Turton, J.A. Chaddock, and K.R. Acharya Botulinum and tetanus neurotoxins: structure, function and therapeutic utility Trends Biochem. Sci. 11 2002 552 558
26. +-PTX) binds to oligosaccharides containing Galβ1-4GlcNAc through one subcomponent of haemagglutinin (HA1) Microbiology 147 2001 811 819
27. N. Yokosawa, Y. Kurokawa, K. Tsuzuki, B. Syuto, N. Fujii, K. Kimura, and K. Oguma Binding of Clostridium botulinum type C neurotoxin to different neuroblastoma cell lines Infect. Immun. 57 1989 272 277
28. I.J. Rosenstein, C.T. Yuen, M.S. Stoll, and T. Feizi Differences in the binding specificities of Pseudomonas aeruginosa M35 and Escherichia coli C600 for lipid-linked oligosaccharides with lactose-related core regions Infect. Immun. 60 1992 5078 5084
29. B.D. Spangler Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin Microbiol. Rev. 56 1992 622 647
30. W.I. Lencer, C. Delp, M.R. Neutra, and J.L. Madara Mechanism of cholera toxin action on a polarized human intestinal epithelial cell line: role of vesicular traffic J. Cell. Biol. 117 1992 1197 1209
31. T. Idota, H. Kawakami, Y. Murakami, and M. Sugawara Inhibition of cholera toxin by human milk fractions and sialyllactose Biosci. Biotechnol. Biochem. 59 1995 417 419
32. M. Watanabe, K. Matsuoka, E. Kita, K. Igai, N. Higashi, A. Miyagawa, T. Watanabe, R. Yanoshita, Y. Samejima, D. Terunuma, Y. Natori, and K. Nishikawa Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections J. Infect. Dis. 189 2004 360 368
33. A. Nishikawa, N. Uotsu, H. Arimitsu, J.C. Lee, Y. Miura, Y. Fujinaga, H. Nakada, T. Watanabe, T. Ohyama, Y. Sakano, and K. Oguma The receptor and transporter for internalization of Clostridium botulinum type C progenitor toxin into HT-29 cells Biochem. Biophys. Res. Commun. 319 2004 327 333